- Lobbying
- Melissa AND Bartlett
Lobbying Arrangements Results for 'Melissa Bartlett'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues pertaining to chronic kidney disease, generally; and issues specifically relating to end-stage renal disease (ESRD) drugs, innovation, and reimbursement (including Medicare coverage and reim... |
Akebia Therapeutics Inc
|
Chamber Hill Strategies | |||
Details Policies impacting managed Medicaid plans; proposals related to dual eligibles at CMMI. |
Commonwealth Care Alliance
|
Chamber Hill Strategies | |||
Details Issues related to hearing health and hearing restoration. |
Frequency Therapeutics Inc.
|
Chamber Hill Strategies | |||
Details Personal protective equipment |
Peak International Partners LLC
|
Chamber Hill Strategies | |||
Details Public policy proposals surrounding women's health |
TherapeuticsMD, Inc.
|
Chamber Hill Strategies | |||
Details Policies impacting hospitals and health systems |
Logan Health (formally known as Kalispell Regional Healthcare)
|
Chamber Hill Strategies | |||
Details Policies related to third party payments; proposals related to integrate care for ESRD beneficiaries. |
U.S. Renal Care
|
Chamber Hill Strategies | |||
Details Policies to support public health access and pandemic preparedness; draft proposals related to the PREVENT Pandemics Act |
CIC Health
|
Chamber Hill Strategies | |||
Details Issues related to hospital area wage index; policies that affect hospitals in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Famili... |
Health and Hospitals, Inc.
|
Chamber Hill Strategies | |||
Details General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act; policies conta... |
National Partnership for Women and Families
|
Chamber Hill Strategies | |||
Details Policies affecting hospitals and health systems |
Covenant HealthCare
|
Chamber Hill Strategies | |||
Details Funding for the Military Burn Research Program Prevention of burns and injury related to home oxygen therapy |
American Burn Association
|
Chamber Hill Strategies | |||
Details Policies to address health disparities in kidney disease, patient literacy, diversity in clinical trial participation, FDA/CMS communications, and Medicare payment modernization, generally, and rel... |
Saghmos Therapeutics, Inc.
|
Chamber Hill Strategies | |||
Details Policies impacting Medicaid managed care organizations; policies related to individuals dually eligible for Medicare and Medicaid; policies affecting health care workforce |
Medicaid Health Plans of America
|
Chamber Hill Strategies | |||
Details Proposals related to therapy cap exceptions and clinical lab payments. |
National Association for the Support of Long Term Care
Trade assoc. representing ancillary of services and products to post-acute care settings |
Chamber Hill Strategies | |||
Details H.R.1839, Medicaid Services and Accountability Act of 2019; Education and issues related to Medicaid; issues related to Medicare Advantage STARS quality program and Medicare Part D; S.1895, Lower H... |
WellCare Health Plans, Inc.
|
Chamber Hill Strategies | |||
Details Affordable Care Act (ACA), ACA subsidies; Telehealth; Mental Health, Mental Health Rule; Site Neutrality/Site Neutral Payment Reform and Fair Hospital Billing; Transparency in Coverage; Surprise Bi... |
Health Care Service Corporation, a Mutual Legal Reserve Company (HCSC)
|
in-house lobbying | |||
Details Issues generally in the Affordable Care Act; issues related to insurance markets and stabilization, transparency, surprise billing, access to and payment for mental health care, and COVID-19 respon... |
Health Care Service Corporation
|
Chamber Hill Strategies | |||
Details Issues pertaining to physician payment and quality measurement, including HR 2474, Strengthening Medicare for Patients and Providers Act; observation care, including HR 5138, Improving Access to Me... |
Society of Hospital Medicine
|
Chamber Hill Strategies | |||
Details General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person pr... |
National Academy of Elder Law Attorneys, Inc.
|
Chamber Hill Strategies | |||
Details Issues pertaining to access to, coverage of and reimbursement for dialysis services and kidney care, including integrated and coordinated care, including but not limited to H.R. 8254/S. 4574, the B... |
American Renal Associates
|
Chamber Hill Strategies | |||
Details Policies that affect hospitals, skilled nursing facilities, and health systems, including proposed regulations to establish nurse staffing ratios in skilled nursing facilities. Policies affecting e... |
Sanford Health
|
Chamber Hill Strategies | |||
Details Affordable Care Act, all provisions and related regulations, including reporting (IRC 6055 and 6056); employer mandate; wellness issues; out-of-pocket (OOP) limits, nondiscrimination, PCORI & comp... |
The ERISA Industry Committee
|
in-house lobbying | |||
Details Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug ... |
BioMarin Pharmaceutical Inc.
|
Chamber Hill Strategies | |||
Details Issues related to prescription-to- over the counter switch; issues related to influenza vaccines; issues related to 340B; issues related to Respiratory Syncytial Virus (RSV) access; issues related ... |
Sanofi US Services Inc.
|
in-house lobbying | |||
Details Medicare Part D coverage and patient access policies ESRD bundling and drug reimbursement issues HCPCS coding and reimbursement decisions Implementation of Patient Protection & Affordable Health Ca... |
GENZYME CORPORATION
|
in-house lobbying | |||
Details FDA modernization policy issues Reauthorization of newborn screening programs General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and ... |
AstraZeneca Pharmaceuticals LP
|
in-house lobbying | |||
Details Issues relating to: Anti Money Laundering; Beneficial Ownership; FinTech Policy, Data Breaches, Privacy Protection; Real Time payments; Industrial Loan Companies (ILCs); Charters. Paycheck Protecti... |
Bank Policy Institute
|
in-house lobbying | |||
Details H.R. 485 - Protecting Health Care For All Patients Act of 2023 - Rep. McMorris Rodgers, Cathy - federal programs using prices based on quality-adjusted life years H.R. 824 - Telehealth Benefit Exp... |
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
|
in-house lobbying |